Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nora Pashayan

Showing results (141-150 of 180) with videos related to

Pageof 18
Sort By:
Cancer Medicine|March 20, 2016
Blood lipids and prostate cancer: a Mendelian randomization analysisCaroline J Bull, Carolina Bonilla, Jeff M P Holly, et al.
The New England Journal of Medicine|April 11, 2025
Assessment of a Polygenic Risk Score in Screening for Prostate CancerJana K McHugh, Elizabeth K Bancroft, Edward Saunders, et al.
Bioinformatics (Oxford, England)|January 1, 2017
SNP interaction pattern identifier (SIPI): an intensive search for SNP-SNP interaction patternsHui-Yi Lin, Dung-Tsa Chen, Po-Yu Huang, et al.
International Journal of Cancer|May 27, 2016
Assessing the role of insulin-like growth factors and binding proteins in prostate cancer using Mendelian randomization: Genetic variants as instruments for circulating levelsCarolina Bonilla, Sarah J Lewis, Mari-Anne Rowlands, et al.
Scientific Reports|April 30, 2021
KLK3 SNP-SNP interactions for prediction of prostate cancer aggressivenessHui-Yi Lin, Po-Yu Huang, Chia-Ho Cheng, et al.
Communications Medicine|May 27, 2026
Polygenic risk score with KLK3 SNP-SNP interaction pairs for predicting prostate cancer aggressivenessHui-Yi Lin, Indrani Sarkar, Harun Mazumder, et al.
European Journal of Human Genetics : EJHG|June 10, 2020
The effect of sample size on polygenic hazard models for prostate cancerRoshan A Karunamuni, Minh-Phuong Huynh-Le, Chun C Fan, et al.
The Prostate|July 17, 2015
Prediction of individual genetic risk to prostate cancer using a polygenic scoreRobert Szulkin, Thomas Whitington, Martin Eklund, et al.
BMJ (Clinical Research Ed.)|January 12, 2018
Polygenic hazard score to guide screening for aggressive prostate cancer: development and validation in large scale cohortsTyler M Seibert, Chun Chieh Fan, Yunpeng Wang, et al.
Nature Communications|September 15, 2018
Identification of multiple risk loci and regulatory mechanisms influencing susceptibility to multiple myelomaMolly Went, Amit Sud, Asta Försti, et al.
Pageof 18

Showing results (141-150 of 180) with videos related to

Sort By:
Pageof 18
Cancer Medicine|March 20, 2016
Blood lipids and prostate cancer: a Mendelian randomization analysisCaroline J Bull, Carolina Bonilla, Jeff M P Holly, et al.
The New England Journal of Medicine|April 11, 2025
Assessment of a Polygenic Risk Score in Screening for Prostate CancerJana K McHugh, Elizabeth K Bancroft, Edward Saunders, et al.
Bioinformatics (Oxford, England)|January 1, 2017
SNP interaction pattern identifier (SIPI): an intensive search for SNP-SNP interaction patternsHui-Yi Lin, Dung-Tsa Chen, Po-Yu Huang, et al.
International Journal of Cancer|May 27, 2016
Assessing the role of insulin-like growth factors and binding proteins in prostate cancer using Mendelian randomization: Genetic variants as instruments for circulating levelsCarolina Bonilla, Sarah J Lewis, Mari-Anne Rowlands, et al.
Scientific Reports|April 30, 2021
KLK3 SNP-SNP interactions for prediction of prostate cancer aggressivenessHui-Yi Lin, Po-Yu Huang, Chia-Ho Cheng, et al.
Communications Medicine|May 27, 2026
Polygenic risk score with KLK3 SNP-SNP interaction pairs for predicting prostate cancer aggressivenessHui-Yi Lin, Indrani Sarkar, Harun Mazumder, et al.
European Journal of Human Genetics : EJHG|June 10, 2020
The effect of sample size on polygenic hazard models for prostate cancerRoshan A Karunamuni, Minh-Phuong Huynh-Le, Chun C Fan, et al.
The Prostate|July 17, 2015
Prediction of individual genetic risk to prostate cancer using a polygenic scoreRobert Szulkin, Thomas Whitington, Martin Eklund, et al.
BMJ (Clinical Research Ed.)|January 12, 2018
Polygenic hazard score to guide screening for aggressive prostate cancer: development and validation in large scale cohortsTyler M Seibert, Chun Chieh Fan, Yunpeng Wang, et al.
Nature Communications|September 15, 2018
Identification of multiple risk loci and regulatory mechanisms influencing susceptibility to multiple myelomaMolly Went, Amit Sud, Asta Försti, et al.
Pageof 18